Page 3 - Nina Mojas News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nina mojas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nina Mojas Today - Breaking & Trending Today

Could GSK myelofibrosis treatment gain EU-first approval?

Could GSK myelofibrosis treatment gain EU-first approval?
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

Nina Mojas , Committee For Medicinal Products Human Use , European Medicines Agency , Medicinal Products , Human Use , Senior Vice President , Oncology Global Product Strategy ,

Australian-developed blood cancer treatment approved by FDA

The FDA has approved GSK's cancer drug Ojjaara (momelotinib) for the treatment of intermediate or high-risk myelofibrosis in adults with anaemia. ....

Nina Mojas , Nemes Laszlo , Andrew Wilks , Senior Vice President , Oncology Global Product Strategy , Professor Andrew , Sierra Oncology , One Marrow Blood Cancer ,

GSK's Ojjaara receives FDA approval to treat myelofibrosis patients with anaemia

GSK's Ojjaara receives FDA approval to treat myelofibrosis patients with anaemia
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Waals Gewest , Nina Mojas , Drug Administration , Janus Kinase ,

US FDA approves GSK treatment for myelofibrosis

GSK announced on Monday that the US Food and Drug Administration (FDA) has granted approval for ‘Ojjaara’, or momelotinib, as a treatment for adults suffering from intermediate or high-risk myelofibrosis with anaemia, including cases of primary myelofibrosis or secondary myelofibrosis. ....

Nina Mojas , Category All , Category Market Report , Category Company News , Category News And Announcements , Category Market Pulse , Category Headline News , Category Sectorial Health Technology ,

FDA Approves Momelotinib to Treat Myelofibrosis Patients With Anemia

Most patients with myelofibrosis will develop anemia over the course of the disease, with more than 30% discontinuing treatment as a result. ....

United States , Kapila Viges , Rubena Mesa , Nina Mojas , National Center , Atrium Health Levine Cancer Center , Research Foundation , National Institutes Of Health , Translational Sciences , Oncology Global Product Strategy , Advancing Translational , National Institutes , Myeloproliferative Neoplasms ,